NewAmsterdam Pharma Company N.V. (NAMS) Free cash flow
NewAmsterdam Pharma Company N.V. (NAMS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to NAMSSource: SEC XBRL filings · For reference only · Not investment advice